Tandem Diabetes Care, Inc.
$21.24
▼
-1.06%
2026-04-21 09:51:01
www.tandemdiabetes.com
NGM: TNDM
Explore Tandem Diabetes Care, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.47 B
Current Price
$21.24
52W High / Low
$29.65 / $9.98
Stock P/E
—
Book Value
$2.27
Dividend Yield
—
ROCE
-26.21%
ROE
-97.89%
Face Value
—
EPS
$-3.04
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
2,500
Beta
1.74
Debt / Equity
289.6
Current Ratio
2.55
Quick Ratio
2.02
Forward P/E
-1,014.28
Price / Sales
1.29
Enterprise Value
$1.47 B
EV / EBITDA
-24.27
EV / Revenue
1.45
Rating
Buy
Target Price
$30.62
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | STERIS plc | $223.73 | 31.17 | $21.95 B | 1.11% | 10.53% | 10.47% | $269.44 / $209.98 | $72.93 |
| 2. | Neogen Corporation | $9.63 | — | $2.08 B | — | -0.05% | -25.57% | $11.43 / $4.32 | $9.68 |
| 3. | Bioventus Inc. | $10.28 | 38.48 | $874.79 M | — | 10.76% | 13.17% | $10.76 / $5.81 | $2.74 |
| 4. | Picard Medical, Inc. | $0.9 | — | $69.69 M | — | -344.07% | 270.74% | $13.68 / $0.9 | $0.05 |
| 5. | InfuSystem Holdings, Inc. | $10.79 | 32.21 | $213.43 M | — | 14.83% | 11.54% | $11.04 / $4.66 | $2.84 |
| 6. | Sintx Technologies, Inc. | $2.78 | — | $11.46 M | — | -185.71% | -3.04% | $6.78 / $1.72 | $0.74 |
| 7. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 290.38 M | 249.25 M | 240.68 M | 234.42 M | 282.65 M | — |
| Operating Profit | 8.29 M | -22.86 M | -31.86 M | -120.88 M | -0.58 M | — |
| Net Profit | -0.59 M | -21.16 M | -52.4 M | -130.56 M | 0.76 M | — |
| EPS in Rs | -0.01 | -0.31 | -0.76 | -1.91 | 0.01 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.01 B | 940.2 M | 747.72 M | 801.22 M |
| Operating Profit | -167.31 M | -99.13 M | -233.23 M | -92.85 M |
| Net Profit | -204.71 M | -96.03 M | -222.61 M | -94.59 M |
| EPS in Rs | -2.99 | -1.4 | -3.25 | -1.38 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 881.11 M | 967.66 M | 952.66 M | 1.05 B |
| Total Liabilities | 725.94 M | 704.56 M | 639.03 M | 612.84 M |
| Equity | 155.17 M | 263.1 M | 313.63 M | 439.95 M |
| Current Assets | 618.14 M | 724.49 M | 747.99 M | 849.98 M |
| Current Liabilities | 242.72 M | 247.05 M | 195.26 M | 165.29 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -9.72 M | 24.23 M | -31.81 M | 50.46 M |
| Investing CF | 72.88 M | -23.48 M | -85.74 M | 33.17 M |
| Financing CF | -43.37 M | 8.37 M | 4.11 M | 16.88 M |
| Free CF | -108.26 M | 4.99 M | -128.11 M | 16.37 M |
| Capex | -98.54 M | -19.23 M | -96.3 M | -34.1 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 25.74% | -6.68% | — | — |
| Earnings Growth % | 56.86% | -135.33% | — | — |
| Profit Margin % | -10.21% | -29.77% | -11.81% | — |
| Operating Margin % | -10.54% | -31.19% | -11.59% | — |
| Gross Margin % | 52.07% | 49.17% | 51.54% | — |
| EBITDA Margin % | -7.42% | -26.27% | -9.26% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.